Also known as Actonel
Risedronic acid (INN) or risedronate sodium (USAN) is a bisphosphonate used to strengthen bone, treat or prevent osteoporosis, and treat Paget's disease of bone. It is produced and marketed by Warner Chilcott, Sanofi-Aventis, and in Japan by Takeda under the trade names Actonel, Atelvia, and Benet. It is also available in a preparation that includes a calcium carbonate supplement, as Actonel with Calcium.
Source: WikipediaEstimated Total Cost: $104.4 for an average of 28 days supply
Patients are most commonly prescribed risedronate to treat osteoporosis, bone disorder, mitral valve disease, and sarcoidosis.
Patients taking risedronate most commonly experience side effects like joint pain, back pain, and headache.